Please Wait...

Global Site Network Sites

Structured to optimize the conduct of clinical research.

With a geographic spread throughout the U.S., Europe, Latin America, and Asia, the Bioclinica Global Site Network brings you the most diverse standardized global site network in the industry. Additionally, we provide a cross-continent, cross-season advantage by being in both the northern and southern hemispheres.

EACH OF OUR RESEARCH SITES IS:

  • Structured and centrally managed to optimize the conduct of clinical research
  • Strategically located to take advantage of access to patient populations
  • Outfitted with state-of-the-art medical testing equipment
  • Staffed by physicians, nurses, study coordinators, technicians and other medical professionals and personnel with therapeutic area specialization
 

Leverage Bioclinica's Expertise

Contact us for more information or to speak with us about how we can support you.

CONTACT US Download Brochure

TECHNOLOGY AND EQUIPMENT

Our innovative technologies enable us to reduce trial complexity, increase efficiency, and provide greater clarity around the effects of the drug being researched so that you can achieve your scientific and business objectives as swiftly as possible.

All our facilities have access to the equipment needed to run various tests, including imaging equipment, MRIs, PET scanners, etc.

DEDICATED SMO SERVICE IN CHINA

The Bioclinica Global Site Network partners with multiple hospitals in China, operating under Bioclinica's patient and project management, SOPs, and quality assurance (QA). Additionally, Bioclinica has an agreement with several hospitals including Peking University Cardiology Department and Beijing Anzhen Cardiology Department to conduct clinical research.

BIOCLINICA GLOBAL SITE NETWORK BY THE NUMBERS

  • 30+ dedicated research centers in 14 countries across four continents
  • Clinics range in size from 600 m2 to 3000 m2 (2000-6500 square feet)
  • Local population covered by a site varies from 300,000 to 20+ million
  • 25,000 patient spaces across the global network
  • Site capacity ranges from 800 to 2500 subjects annually
  • Daily site capacity range 50-125 visits per day
  • Total number of employees is approximately 975
  • Proprietary database of >300,000 patients

ADDITIONAL RESOURCES

Site Network

Download Brochure

Lost To Follow-Up

Download Brochure

WHY CHOOSE A SITE NETWORK FOR YOUR CLINICAL TRIALS?

DOWNLOAD WHITE PAPER

FINDING PATIENTS LOST TO FOLLOW-UP

DOWNLOAD WHITE PAPER

Latin America: An Untapped Clinical Trials Resource

Download White Paper

5 WAYS TO IMPROVE ALZHEIMER'S CLINICAL TRIALS

Download Playbook

LOST TO FOLLOW-UP INFOGRAPHIC

DOWNLOAD INFOGRAPHIC

Alzheimer's Disease

Download Info Sheet

Cardiovascular Outcome Studies

Download Info Sheet

Endo-Diabetes

Download Info Sheet

Osteoarthritis Expertise

Download Info Sheet

Vaccine Development

Download Info Sheet

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Is your clinical study supply chain management solution increasing the risk of stock out? Ehsan Ramezani gives pers… https://t.co/YCfP3wCvK6
Bioclinica (13 hours ago)
Bioclinica's Kate Adamczuk is presenting at #HAI2019 today! Details on this and other scientific findings at HAI… https://t.co/wDQr6ldfcS
Bioclinica (19 hours ago)
What’s the effect of verubecestat on amyloid load in prodromal Alzheimer's disease patients? #HAI2019 attendees ca… https://t.co/j2116PTe8G
Bioclinica (19 hours ago)
Bioclinica's David Scott is presenting at #HAI2019 tomorrow! Want to know more? Reach out to authors: David Scott,… https://t.co/uXArmnkCrn
Bioclinica (Yesterday)
EPOCH trial findings are on display this week at #HAI2019 in Board 138 in Friday morning’s poster session. View HAI… https://t.co/KuiII8KmJo
Bioclinica (Yesterday)
At #HAI2019? Drop by Poster Session 1 on Wed. from 2-3:30 for a presentation by Bioclinica’s Kate Adamczuk, (board… https://t.co/UUOsBdqQVh
Bioclinica (2 days ago)

Latest Blogs:

Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box
Latin America: Benefit from the Right Partner